Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

 
 

Adaptive Biotechnologies Corp (ADPT) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $28.90 Metrics
OS: 144.6 M
Market cap: $4.18 B
Net cash: $417 M $2.88 per share
EV: $3.76 B

 
TTM Valuation
EBITDA ($230) M
EBIT
EPS

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17
Revenues154.398.485.155.738.4
            Revenue growth56.9%15.6%52.8%44.8% 
Cost of goods sold49.322.522.319.715.7
Gross profit105.075.962.836.022.8
            Gross margin68.1%77.1%73.8%64.7%59.2%
Sales and marketing95.561.438.524.516.8
Research and development142.3116.170.739.232.0
General and administrative74.549.530.320.415.9
EBITA-207.3-151.1-76.7-48.1-41.9
            EBITA margin-134.3%-153.6%-90.2%-86.3%-109.1%
Amortization of intangibles1.71.71.71.71.7
EBIT-209.0-152.8-78.4-49.8-43.6
            EBIT margin-135.4%-155.3%-92.1%-89.4%-113.5%
Pre-tax income-207.3-146.2-68.6-46.4-42.8
Income taxes0.00.00.00.00.0
            Tax rate0.0%0.0%0.0%0.0%0.0%
Net income-207.3-146.2-69.6-46.3-42.7
            Net margin-134.3%-148.6%-81.8%-83.3%-111.0%
 
Diluted EPS($1.48)($1.11)($1.01)($3.67)($3.50)
Shares outstanding (diluted)140.4131.269.212.612.2
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy